Evidence map›Paper›PMID 39617059›Full record

ArticleOphthalmology2025

Longitudinal Assessment of Age-Related Macular Degeneration Using Ultrawidefield Imaging: The Optos Peripheral Retina Follow-up Study.

Colin P Froines, Jeong W Pak, Elvira Agrón, Emily Y Chew, Tunde Peto, Barbara A Blodi, Amitha Domalpally

Abstract readMulticenter Study
In one paragraph

Article in Ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Impaired Rod-Mediated Vision is the Functional Hallmark of Ageing and Early and Intermediate Age-Related Macular Degeneration.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Colin P FroinesDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Jeong W PakDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Elvira AgrónDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Emily Y ChewDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Tunde PetoCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Barbara A BlodiDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Amitha DomalpallyDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin. Electronic address: domalpally@wisc.edu.

Funding

The Age-Related Eye Disease Study 2 (AREDS2)ZIAEY000485 · NEI · NATIONAL EYE INSTITUTE · PI CHEW, EMILY Y · 2009 to 2015
$990k
Intramural NIH HHS ZIA EY000485
6 · The paper itself

Abstract

purposeWith the widespread availability of Ultrawidefield (UWF) imaging, peripheral retinal abnormalities in age-related macular degeneration (AMD) have garnered attention. However, longitudinal studies of AMD peripheral findings are limited. This study aimed to characterize and quantify these features over 5 years.

designLongitudinal ancillary study.

participantsThe Optos Peripheral Retina (OPERA) study was an ancillary study of the Age-Related Eye Disease Study 2. A total of 137 participants (265 eyes) in the OPERA study with gradable UWF color and autofluorescence imaging at years 5 and 10 were included.

methodsUltrawidefield color and autofluorescence images were captured using Optos UWF devices and were graded at the Wisconsin Reading Center for macular and peripheral AMD features using the 3-zone OPERA study grid.

main outcome measuresPresence of peripheral retinal lesions (neovascular AMD, geographic atrophy [GA], drusen, increased pigment, decreased pigment, reticular pseudodrusen, reticular pigmentary changes, and cobblestone degeneration) and their association with central AMD progression.

resultsIn zone 1 at year 5 and year 10, the AMD severity scale (AMDSS) score was ≤ 5 in 8% and 6%, 6 to 8 in 49% and 30%, noncentral and central GA in 15% and 27%, and neovascular AMD in 28% and 37%, respectively. In zone 2, peripheral AMD abnormalities in year 5 versus year 10 included: drusen, 99% versus 99%; hyperpigmentation, 11% versus 11%; and hypopigmentation, 4% versus 7%, respectively. Peripheral degenerations not associated with AMD were present in year 5 versus year 10 as follows: cobblestone, 19% versus 30%; and reticular pigmentary changes, 25% versus 33%, respectively. Among eyes with an AMDSS level of 6 to 8 at year 5, progression to late AMD occurred in 41% without substantial peripheral findings and in 41% with such findings, which include drusen of ≥ 1 disc area, any hypopigmentation or hyperpigmentation in zones 2 or 3, or a combination thereof.

conclusionsThe OPERA study revealed that AMD features often extend beyond the macula, suggesting that AMD is a panretinal disease. In this study, peripheral findings were not associated with increased risk of progression to late AMD. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

RetinaWet Macular DegenerationAgedAged, 80 and overDisease ProgressionFemaleFluorescein AngiographyFollow-Up StudiesGeographic AtrophyHumansLongitudinal StudiesMaleMiddle AgedRetinal DrusenTomography, Optical CoherenceVisual AcuityAge-related macular degenerationPeripheral retinal findingsUltrawide-field photography

Identifiers

PMID39617059
PMCPMC12018143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.